All Categories
Refine Search
CP-465022 Maleate
Novel class of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate(NMDA) receptor antagonist
CPI-613
An E1α pyruvate dehydrogenase (PDH) modulator that prevents cancer cells from metabolizing glucose for energy. CPI-613 has been granted orphan drug status by the US FDA for pancreatic cancer
CPI203
Novel potent, selective and cell permeable inhibitor of the bromodomain and extra terminal (BET) family protein BRD4
CPTH6 HBr
Novel inducer of histone hypoacetylation and apoptosis in human leukemia cell, impairing autophagy
